Large-scale testing (Phase 3)Study completedNCT00121407What this trial is testingVisudyne® in Occult (VIO)Who this might be right forMacular Degeneration QLT Inc. 364
Testing effectiveness (Phase 2)Study completedNCT00288561What this trial is testingStudy of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular DegenerationWho this might be right forAge-Related Macular Degeneration (ARMD) Novartis
Large-scale testing (Phase 3)UnknownNCT00454389What this trial is testingStrontium90 Beta Radiation With Lucentis to Treat Age-Related Macular DegenerationWho this might be right forMacular Degeneration NeoVista 494
Testing effectiveness (Phase 2)Ended earlyNCT01122511What this trial is testingSafety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular DegenerationWho this might be right forSubfoveal Choroidal NeovascularizationAge-Related Maculopathy Allergan 4
Post-approval studies (Phase 4)Study completedNCT04679935What this trial is testingEfficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Study completedNCT00284089What this trial is testingSafety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular DegenerationWho this might be right forSubfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD) Novartis 88
Testing effectiveness (Phase 2)Study completedNCT00239928What this trial is testingClinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular DegenerationWho this might be right forMacular Degeneration Pfizer 61
Large-scale testing (Phase 3)Study completedNCT00331864What this trial is testingSUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular DegenerationWho this might be right forAge Related Macular DegenerationChoroidal Neovascularization Novartis 531
Early research (Phase 1)Study completedNCT00503022What this trial is testingSafety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular DegenerationWho this might be right forWet Age-Related Macular Degeneration Novartis 20
Testing effectiveness (Phase 2)Study completedNCT00138632What this trial is testingSafety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)Who this might be right forWet Age-Related Macular Degeneration Novartis 50
Testing effectiveness (Phase 2)Ended earlyNCT00090532What this trial is testingThe Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular DegenerationWho this might be right forAge-Related Macular Degeneration Pfizer 155
Large-scale testing (Phase 3)Ended earlyNCT00139282What this trial is testingA Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular DegenerationWho this might be right for"Wet" Age-Related Macular Degeneration Genaera Corporation
Testing effectiveness (Phase 2)UnknownNCT00032396What this trial is testingEvaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular DegenerationWho this might be right forMacular Degeneration Control Delivery Systems
Post-approval studies (Phase 4)Study completedNCT00504959What this trial is testingSafety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular DegenerationWho this might be right forSubfoveal Choroidal Neovascularization (CNV)Secondary to Age-related Macular Degeneration (AMD) Novartis 234
Testing effectiveness (Phase 2)Study completedNCT00259753What this trial is testingSafety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular DegenerationWho this might be right forMacular Degeneration OPKO Health, Inc. 120
Large-scale testing (Phase 3)WithdrawnNCT00930189What this trial is testingComparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal NeovascularizationWho this might be right forSubfoveal Choroidal Neovascularization Asociación para Evitar la Ceguera en México
Large-scale testing (Phase 3)Study completedNCT03844074What this trial is testingA Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)Who this might be right forAge-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration Outlook Therapeutics, Inc. 61
Not applicableStudy completedNCT00088192What this trial is testingIntravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)Who this might be right forMacular Degeneration Eyetech Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00275821What this trial is testingEfficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)Who this might be right forAge Related Macular Degeneration Novartis 353
Testing effectiveness (Phase 2)Study completedNCT00426998What this trial is testingCombination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMDWho this might be right forChoroidal NeovascularizationMacular Degeneration Retinal Consultants Medical Group 30